Public Market Listing
Live quotes, historical charts, and market capitalization for InventisBio are available on Yahoo Finance.
View quote & market cap on Yahoo Finance ↗External market data link · No third-party exchange redistribution
Assets
(4 total)
| Target & Modality | |||
|---|---|---|---|
| Phase 3 | EGFRSmall molecule | Non-Small Cell Lung Cancer | |
Garsorasib(Anfangning) | Phase 3 | KRAS G12CSmall molecule | Non-Small Cell Lung Cancer |
| Phase 3 | TYK2Small molecule | Inflammatory Bowel DiseasePsoriasisSystemic Lupus ErythematosusVitiligo Ulcerative Colitis | |
| Phase 3 | Estrogen receptorSmall molecule | Breast Cancer HR+/HER2- Metastatic Breast Cancer |
Upcoming events
(10 total)
Estimated primary-completion dates from ClinicalTrials.gov and expected earnings reports. These are registry estimates, never confirmed readout dates; they can move as trials progress.
Add these trial readouts to your calendar: Apple or Outlook · Google Calendar · .ics link. The calendar updates when a registry date moves.
2026 (1)
November 2026 (1)
What to watch
2027 (6)
July 2027 (2)
August 2027 (2)
November 2027 (1)
What to watch
December 2027 (1)
What to watch
Regulatory and conference events
(2)
Filings, regulator decisions, scientific presentations, topline results and licensing deals, each from a dated source. When a source gives only the month, the month is shown.
Recent